Celldex Therapeutics shares owned by ProShare Advisors
Quarter-by-quarter ownership of Celldex Therapeutics (CLDX) shares owned by ProShare Advisors
from 13F filings
Historical chart of ProShare Advisors investment in Celldex Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Celldex Therapeutics held by ProShare Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csvQuarterly reported holdings in Celldex Therapeutics by ProShare Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-12-31 | $325k | 12k | 27.16 |
| 2025-09-30 | $290k | 11k | 25.87 |
| 2025-06-30 | $273k | 13k | 20.35 |
| 2025-03-31 | $254k | 14k | 18.15 |
| 2024-12-31 | $460k | 18k | 25.27 |
| 2024-09-30 | $415k | 12k | 33.99 |
| 2024-06-30 | $308k | 8.3k | 37.01 |
| 2024-03-31 | $469k | 11k | 41.97 |
| 2023-06-30 | $205k | 6.0k | 33.93 |
| 2022-12-31 | $263k | 5.9k | 44.57 |
| 2022-03-31 | $293k | 8.6k | 33.96 |
| 2021-12-31 | $388k | 10k | 38.64 |
| 2021-09-30 | $318k | 5.9k | 53.94 |
| 2021-06-30 | $340k | 10k | 33.43 |